PharmaPrint Inc.:
- Share via
The Irvine development-stage company that makes foods, supplements and pharmaceuticals from natural sources reported a net loss of $6.6 million, or 48 cents a share, for the second fiscal quarter, compared with a net loss of $8 million, or 59 cents a share, for the same period last year. Revenue fell to $589,774 from $4 million.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
